Skip to content

Fibrinogen Concentrate and Placenta Acreta Spectrum

Is the Use of Fibrinogen in Cesarean Section Related to Bleeding and Blood Product in Patients With Placenta Accreta Spectrum?: a Retrospective Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05938062
Enrollment
146
Registered
2023-07-10
Start date
2022-01-01
Completion date
2023-05-01
Last updated
2023-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstetric Anesthesia Problems, Placenta Accreta

Keywords

fibrinogen concentrate, obstetric anesthesia, plasenta acreata spectrum, postpartum hemorrhage

Brief summary

The aim of this study is to evaluate the relationship between fibrinogen use and bleeding in patients who underwent cesarean section with a prediagnosis of PAS. The key question(s) it aims to answer are: \[Does the use of fibrinogen concentrate reduce bleeding in PAS patients?\] Patients who had a cesarean section with a pre-diagnosis of PAS were analyzed retrospectively. The choice of anesthesia applied to the patients and the relationship between the use of blood products and bleeding were evaluated.

Detailed description

Our study was designed as a retrospective randomized study. Patients aged 20-50 years and \>34 weeks of gestation who accepted the birth with a cesarean section with a pre-diagnosis of PAS were evaluated retrospectively. examined. were randomized into 2 groups, 53 patients in each group: group1: GNF : the group without fibrinogen concentrate Group 2: GF: the group with fibrinogen concentrate

Interventions

PROCEDUREthe group without fibrinogen concentrate (GNF) , the group with fibrinogen concentrate (GF)

the group without fibrinogen concentrate (GNF, ) the group with fibrinogen concentrate (GF)

Sponsors

Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Masking description

retrospective randomized study

Intervention model description

retrospective randomized study

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 20-50 years PAS pre-diagnosed pregnant women * \>34 weeks of pregnancy * Those with normal renal functions

Exclusion criteria

* Patients with renal insufficiency * Those with \<34 weeks of gestation * Pregnant women with missing data

Design outcomes

Primary

MeasureTime frameDescription
Laboratory hemoglobin level(g/dl)Change from preoperative to postoperative day 1(POD 1) hemoglobin values (g/dl).Our primary aim was to evaluate the postoperative day 1(POD 1) hemoglobin values(g/dl).

Secondary

MeasureTime frameDescription
The intensive care unit (ICU) admission and length of stay.postoperatively up to 1 monthsThe secondary aim was to investigate the intensive care unit (ICU) admission and length of stay.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026